| Nephrotic syndrome secondary to amyloidosis. | |
| | |
MedLine Citation:
|
PMID: 10884998 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Nephrotic syndrome represents a constellation of symptoms including hyperalbuminuria, hypoalbuminemia, edema formation, hypercholesterolemia, hypertension, hypercoagulopathy, and increased infection risk. The hallmark of this syndrome is proteinuria greater than 3.5 grams per 24 hours, and the clinical features are secondary manifestations of an underlying primary glomerular or systemic disease. The objectives of treatment are threefold: correcting the primary disease, decreasing the symptoms and secondary effects associated with this syndrome, and preventing complications. This article presents a case report of a man diagnosed with nephrotic syndrome secondary to amyloidosis. The clinical aspects of the disease processes, the diagnostic evaluation, the treatment course, and disease management are discussed. |
| | |
Authors:
|
S Kneipp; S B Himmelstein |
Related Documents
:
|
3802598 - Nephrotic syndrome preceding hodgkin's disease by 42 months. 12119488 - Cyclosporin a treatment for membranoproliferative glomerulonephritis type ii. 865128 - Nephrotic syndrome associated with gastric cancer. 8846138 - Nephrotic syndrome accompanying familial hemophagocytic syndrome. 11586288 - Time for t. 16945518 - Reversible posterior leucoencephalopathy syndrome in a peripartum patient. |
Publication Detail:
|
Type: Case Reports; Journal Article; Review |
Journal Detail:
|
Title: The Nurse practitioner Volume: 25 ISSN: 0361-1817 ISO Abbreviation: Nurse Pract Publication Date: 2000 Jun |
Date Detail:
|
Created Date: 2000-10-30 Completed Date: 2000-10-30 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 7603663 Medline TA: Nurse Pract Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 78, 81, 85-6 passim Citation Subset: IM; N |
Affiliation:
|
University of Florida College of Nursing, Gainesville, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Amyloidosis / complications*, diagnosis*, therapy Anti-Inflammatory Agents / therapeutic use Antineoplastic Agents, Alkylating / therapeutic use Biopsy Combined Modality Therapy Diagnosis, Differential Hematopoietic Stem Cell Transplantation Humans Male Medical History Taking / methods Melphalan / therapeutic use Nephrotic Syndrome / diagnosis*, etiology*, metabolism, therapy Physical Examination / methods Prednisone / therapeutic use Referral and Consultation |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Inflammatory Agents; 0/Antineoplastic Agents, Alkylating; 148-82-3/Melphalan; 53-03-2/Prednisone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Establishing the etiology of thrombocytopenia.
Next Document: The challenges of diagnosing erectile dysfunction in the primary care setting.